BlackRock
MAIA icon

BlackRock’s MAIA Biotechnology MAIA Stock Holding History

BlackRock’s Portfolio MAIA Stock Details MAIA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$179K Buy
127,978
+20,733
+19% +$38.2K ﹤0.01% 4803
2025
Q4 		$164K Buy
107,245
+2,388
+2% +$3.12K ﹤0.01% 4781
2025
Q3 		$161K Buy
104,857
+1,592
+2% +$2.6K ﹤0.01% 4728
2025
Q2 		$186K Buy
103,265
+19,182
+23% +$34.3K ﹤0.01% 4692
2025
Q1 		$129K Sell
84,083
-702
-0.8% -$1.3K ﹤0.01% 4705
2024
Q4 		$168K Buy
84,785
+5,058
+6% +$12.1K ﹤0.01% 4656
2024
Q3 		$224K Buy
79,727
+1,206
+2% +$3.76K ﹤0.01% 4507
2024
Q2 		$269K Buy
78,521
+61,529
+362% +$194K ﹤0.01% 4488
2024
Q1 		$37.4K Sell
16,992
-217
-1% -$326 ﹤0.01% 4933
2023
Q4 		$20.1K Buy
17,209
+3,237
+23% +$5.22K ﹤0.01% 5084
2023
Q3 		$30.7K Buy
13,972
+5,955
+74% +$11.8K ﹤0.01% 5085
2023
Q2 		$17.6K Buy
8,017
+4,011
+100% +$10.7K ﹤0.01% 5212
2023
Q1 		$13.9K Buy
4,006
+132
+3% +$542 ﹤0.01% 5292
2022
Q4 		$13.6K Buy
3,874
+302
+8% +$1.04K ﹤0.01% 5423
2022
Q3 		$12K Buy
+3,572
New +$15.1K ﹤0.01% 5574

Other funds holding MAIA

SCM
Solas Capital Management Darien, Connecticut $174M AUM 6.33% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
CWM
Centric Wealth Management Chicago, Illinois $501M AUM 15.27% 1-Year Est. Return
CCC
Cable Car Capital San Francisco, California $289M AUM 26.33% 1-Year Est. Return
BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BlackRock's MAIA Position: Q1 2026 in Review

BlackRock increased its MAIA Biotechnology (MAIA) stake by 19% in Q1 2026, buying an estimated $38.2K and bringing the position to 127,978 shares worth $179K. The position accounts for ﹤0.01% of the portfolio, ranked #4803.

BlackRock first reported a position in MAIA in Q3 2022 and has held it in 15 quarters since. The position peaked at $269K in Q2 2024. 33 funds tracked by Wall St. Rank hold MAIA as of Q1 2026.

  • BlackRock held 127,978 shares of MAIA Biotechnology worth $179K as of Q1 2026.
  • BlackRock bought 20,733 MAIA Biotechnology shares in Q1 2026, an estimated $38.2K.
  • MAIA Biotechnology made up ﹤0.01% of BlackRock's portfolio in Q1 2026, its #4803 holding.
  • BlackRock first reported a position in MAIA Biotechnology in Q3 2022 and has held it in 15 quarters since.
  • BlackRock's MAIA Biotechnology position peaked at $269K in Q2 2024.
  • 33 funds tracked by Wall St. Rank held MAIA Biotechnology as of Q1 2026.

Based on BlackRock's 13F filing for Q1 2026, filed 13 May 2026.